Drew Coiner PTA

Recommended Articles

• What are the Causes and Symptoms of Cervical Cancer?

  Abnormal growth and division of the cells in the cervix leads to cervical cancer. The cervix is the part of the female body that connects the uterus to the vagina. The abnormal cells become invasive and they may invade other organs, like lungs, liver, bladder, and even rectum. As the disease...

• Reasons Why You Need Occupational Therapy

  Our days go by with daily occupations. These occupations represent who we really are in life. Different occupations performed daily may include different roles like being a husband, wife, parent, child, football player, tennis player, an actor, musician, doctor, firefighter, etc. Our occupations...

• Autism: How to Handle a Child Running Away from School

  As many know, children with autism spectrum disorder are prone to wandering behaviors, leading to a constant worry for many parents. These worries came true recently when a child ran away from school in East Harlem. While these dangers are always present, there are certain precautions both parents...

• Carrie Fisher's Death Leads to Increased Concern Over Sleep Apnea

  Long-time actress and author Carrie Fisher will probably be best remembered as playing her iconic role of Princess Leia in George Lucas’s cult classic Star Wars. When news of her death reached the internet, fans of the beloved series were shocked and eager to find the cause, especially since her...

• Stress Can Lead to Binge Eating

  According to a new survey presented at the annual meeting of American Psychological Association, there are those that lose their appetite when under stress but for the most part, people tend to overeat at the time of stress. The study conducted under the leadership of Kayla Ten Eycke, MSc, of the...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...